Handbook of Bioequivalence Testing

AvSarfaraz K. Niazi

E-bok

PDF, Engelska, 2014

Del i serien Drugs and the Pharmaceutical Sciences

787 kr

Läs direkt i Bokus Reader – eller ladda ned till din enhet (PDF kräver ofta zoom och scroll på små skärmar).

Fler format och utgåvor

Häftad

671 kr

E-bok

789 kr

Inbunden

2 969 kr

Beskrivning

As the generic pharmaceutical industry continues to grow and thrive, so does the need to conduct adequate, efficient bioequivalence studies. In recent years, there have been significant changes to the statistical models for evaluating bioequivalence. In addition, advances in the analytical technology used to detect drug and metabolite levels have m

Produktinformation

Utgivningsdatum:2014-10-29
Språk:Engelska
Filformat:PDF
Kopieringsskydd:LCP
ISBN:9781482226386
Förlag:Taylor & Francis Ltd
Upplaga:2
Serie:Drugs and the Pharmaceutical Sciences

Utforska kategorier

Tillverkningsteknik inom Naturvetenskap och teknik
Farmakologi inom Medicin
Naturvetenskap:allmänt inom Naturvetenskap och teknik

Mer om författaren

Sarfaraz K. Niazi, PhD, is the chairman and CEO of Therapeutic Proteins International, a world-class developer and manufacturer of biosimilar recombinant drugs. The company now leads the world in using innovative methods of manufacturing biosimilar recombinant drugs coming off-patents. He employs hundreds of world's top scientists working toward the goal of making life-saving biological drugs more affordable. He has published over 100 refereed research articles and abstracts, dozens of books, and hundreds of literary writings that span the vast areas of poetry, philosophy, rhetoric, irony, and modern dilemma.

Recensioner i media

"This handbook offers a complete description of every aspect of bioequivalence testing ... [It] is an essential, one-of-a-kind resource for anyone interested in bioequivalence. There are no other books that compile so many aspects in one place." -Jennifer L. Colon, PharmD, Temple University School of Pharmacy, in Doody's Review Service

Innehållsförteckning

Historical Perspective on Generic Pharmaceuticals. Physicochemical Basis of Bioequivalence Testing. Drug Delivery Factors. Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling. Bioequivalence Testing Rationale and Principles. Bioequivalence Waivers. Statistical Evaluation of Bioequivalence Data. Regulatory Inspection Process. Fed Bioequivalence Studies. Topical Drugs. Bioequivalence of Nasal Products. Bioequivalence of Complementary and Alternate Medicines. Bioequivalence of Biosimilar Products. Bioequivalence Testing: The US Perspective. Bioequivalence Testing: European Perspective. Bioequivalence Testing: The ROW Perspective. Bioequivalence Testing Protocols. Bioequivalence Documentation. Good Laboratory Practices. Bioanalytical Method Validation. Good Clinical Practice. Computer and Software Validation. Outsourcing and Monitoring of Bioequivalence Studies. Epilogue: Future of Bioequivalence Testing. Appendix A: Glossary of Terms. Appendix B: Dissolution Testing Requirements for US FDA Submission. Bibliography. Index.